Ascendis Pharma A/S

ASNDNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$16.694 B

$253.39 -1.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Ascendis Pharma A/S (ASND) has a market capitalization of $16.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

61,977,408

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#24ViatrisVTRS$21.8B
#25Alnylam PharmaceuticalsALNY$21.0B
#26Ascendis Pharma A/SASND$16.7B
#27Jazz PharmaceuticalsJAZZ$14.6B
#28BridgeBio PharmaBBIO$14.5B

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Ascendis Pharma A/S, worth $492.7K. Grants and option exercises are excluded.

Jean Jacques Bienaime$492.7K
2,000 shares at $246.33 on 14 Aug 2026 · filed 18 Aug 2026

What if Ascendis Pharma A/S were worth as much as…

Open the what-if tool →

Gold $28.2T

$428,584.07

Per share 1,691× higher

Bitcoin $1.53T

$23,189.94

Per share 91.5× higher

Apple $5.02T

$76,130.40

Per share 300× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Ascendis Pharma A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.